{"title":"Coloproctectomie pour polypose adénomateuse familiale et autres polyposes","authors":"Benjamin Fernandez , Étienne Buscail","doi":"10.1016/j.bulcan.2024.12.014","DOIUrl":null,"url":null,"abstract":"<div><div>La coloproctectomie pour polypose adénomateuse familiale est une procédure chirurgicale souvent nécessaire pour prévenir le développement de cancers colorectaux chez les patients atteints de cette pathologie. La polypose adénomateuse familiale est une maladie héréditaire caractérisée par le développement de centaines, voire de milliers, de polypes adénomateux dans le côlon et le rectum. Le traitement standard pour éviter la progression vers le cancer est souvent une coloproctectomie, qui implique l’ablation chirurgicale du côlon et du rectum (Jasperson et al., 1993–2017; Grover et Syngal, 2010). D’autres polyposes héréditaires, comme la polypose associée au syndrome de Peutz-Jeghers ou la polypose hyperplasique, peuvent également nécessiter des approches chirurgicales similaires (Jasperson et al., 1993–2017).</div></div><div><div>Coloproctectomy for familial adenomatous polyposis (FAP) is a surgical procedure often required to prevent the development of colorectal cancer in patients with this condition. FAP is an inherited disease characterized by the development of hundreds, or even thousands, of adenomatous polyps in the colon and rectum. The standard treatment to prevent progression to cancer is often coloproctectomy, which involves surgical removal of the colon and rectum. Other hereditary polyposis, such as Peutz-Jeghers syndrome or hyperplastic polyposis, may also require similar surgical approaches.</div></div>","PeriodicalId":9365,"journal":{"name":"Bulletin Du Cancer","volume":"112 3","pages":"Pages 253-258"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin Du Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S000745512500030X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
La coloproctectomie pour polypose adénomateuse familiale est une procédure chirurgicale souvent nécessaire pour prévenir le développement de cancers colorectaux chez les patients atteints de cette pathologie. La polypose adénomateuse familiale est une maladie héréditaire caractérisée par le développement de centaines, voire de milliers, de polypes adénomateux dans le côlon et le rectum. Le traitement standard pour éviter la progression vers le cancer est souvent une coloproctectomie, qui implique l’ablation chirurgicale du côlon et du rectum (Jasperson et al., 1993–2017; Grover et Syngal, 2010). D’autres polyposes héréditaires, comme la polypose associée au syndrome de Peutz-Jeghers ou la polypose hyperplasique, peuvent également nécessiter des approches chirurgicales similaires (Jasperson et al., 1993–2017).
Coloproctectomy for familial adenomatous polyposis (FAP) is a surgical procedure often required to prevent the development of colorectal cancer in patients with this condition. FAP is an inherited disease characterized by the development of hundreds, or even thousands, of adenomatous polyps in the colon and rectum. The standard treatment to prevent progression to cancer is often coloproctectomy, which involves surgical removal of the colon and rectum. Other hereditary polyposis, such as Peutz-Jeghers syndrome or hyperplastic polyposis, may also require similar surgical approaches.
期刊介绍:
Without doubt, the ''Bulletin du Cancer'' is the French language publication of reference in the field of cancerology. Official organ of the French Society of Cancer, this journal covers all the information available, whether in the form of original articles or review articles, but also clinical cases and letters to the editor, including various disciplines as onco-hematology, solids tumors, medical oncology, pharmacology, epidemiology, biology as well as fundamental research in cancerology. The journal proposes a clinical and therapeutic approach of high scientific standard and regular updates in knowledge are thus made possible. Articles can be submitted in French or English.